- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Primary Myelofibrosis
Total 59820 results
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruiting
-
Keros Therapeutics, Inc.IQVIA BiotechRecruitingMyelofibrosisAustralia
-
Karyopharm Therapeutics IncRecruitingMyelofibrosisUnited States, Korea, Republic of, Spain, France, Italy, Israel, Czechia, Canada, Germany, Romania, Bulgaria, Poland
-
University of MichiganNational Cancer Institute (NCI); SanofiRecruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Celgene; Incyte CorporationActive, not recruitingMyelofibrosisUnited States
-
AbbVieCompletedMyelofibrosisArgentina, Australia, Brazil, Canada, Colombia, Greece, Italy, Mexico, Poland, Portugal, Romania, Taiwan, Turkey, United States
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
John MascarenhasCompleted
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Completed
-
Novartis PharmaceuticalsCompletedMyelofibrosisUnited Kingdom, Germany, Canada, Singapore, Netherlands, Italy, Australia, France
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationAvailable
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Margherita MaffioliUnknown
-
University Hospital, BrestCompleted
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLCTerminated
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Myeloproliferative...CompletedMyelofibrosisUnited States, Canada, Italy, Sweden
-
Weill Medical College of Cornell UniversityCompleted
-
Cellenkos, Inc.Recruiting
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdRecruiting
-
Bristol-Myers SquibbActive, not recruitingMyelofibrosisItaly, Spain, United States, Australia, France, Germany, Greece, Hungary, Israel, Korea, Republic of, Poland, Romania
-
French Innovative Leukemia OrganisationCompleted
-
PharmaMarCompletedMyelofibrosisUnited States, Italy
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Actuate Therapeutics Inc.Completed
-
Ascentage Pharma Group Inc.WithdrawnMyelofibrosisUnited States
-
Hamad Medical CorporationUnknownEssential Thrombocythemia | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic StageQatar
-
Marina KremyanskayaIncyte CorporationWithdrawnMyelofibrosis | MF
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
PfizerTerminatedPrimary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia MyelofibrosisUnited States, Japan
-
M.D. Anderson Cancer CenterCephalonCompleted
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myeloproliferative Disorders | Secondary Myelofibrosis
-
University Hospital, AngersRecruitingEssential Thrombocythemia | Myeloproliferative Disorder | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic StageFrance
-
Incyte CorporationNovartisCompletedMyelofibrosisFrance, United Kingdom, China, United States, Netherlands, Germany, Italy, Austria
-
Imago BioSciences, Inc., a subsidiary of Merck...CompletedMyelofibrosis | Primary Myelofibrosis (PMF) | Post-polycythemia Vera Myelofibrosis (PPV-MF) | Post-essential Thrombocythemia Myelofibrosis (PET-MF)Germany, United States, Australia, Italy, United Kingdom
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis (PMF) | Post Polycythaemia Myelofibrosis (PPV MF) | Post Essential Thrombocythaemia Myelofibrosis (PET-MF)United Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Incyte CorporationActive, not recruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedMyeloproliferative DiseasesUnited States
-
Kartos Therapeutics, Inc.RecruitingPrimary Myelofibrosis (PMF) | Post-Polycythemia Vera Myelofibrosis (Post-PV-MF) | Post-Essential Thrombocythemia Myelofibrosis (Post-ET-MF)United States, Mexico, Bulgaria, Poland, Russian Federation, Belarus, Georgia, South Africa, Ukraine
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingSecondary MyelofibrosisUnited States
-
CelgeneCompletedMyelofibrosis | Myeloid Metaplasia | Myelofibrosis With Myeloid MetaplasiaUnited States, Italy, United Kingdom, Austria, Spain
-
Central Hospital, Nancy, FranceCompleted
-
M.D. Anderson Cancer CenterHelsinn Healthcare SACompletedMyeloproliferative DiseasesUnited States
-
St. Petersburg State Pavlov Medical UniversityCompletedPrimary Myelofibrosis | Myeloproliferative DisordersRussian Federation
-
CTI BioPharmaSGS S.A.CompletedMyelofibrosisMoldova, Republic of, Germany, Romania